Timing of surgical intervention for the intact primary in stage IV breast cancer patients

Roshni Rao, Lei Feng, Henry M. Kuerer, S. Eva Singletary, Isabelle Bedrosian, Kelly K. Hunt, Merrick I. Ross, Gabriel N. Hortobagyi, Barry W. Feig, Frederick C. Ames, Gildy V. Babiera

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Background: Recent studies demonstrate improved progression-free survival (PFS) and improved overall survival (OS) with extirpation of the primary tumor in breast cancer patients who present with metastatic disease at initial diagnosis. The subset of patients who would most benefit from surgery remains unclear. This study evaluates the pathological attributes and optimum timing for surgery in patients who present with stage IV breast cancer and an intact primary. Methods: Retrospective, single-institution review of all breast cancer patients between 1997 and 2002 presenting with an intact tumor and synchronous metastatic disease. Information collected included: demographics, tumor characteristics, metastatic sites, type/timing of surgery, and radiation/systemic therapy received. Patients initiated treatment within 3 months of their diagnosis. Patients were divided into three groups based on time interval from diagnosis date to surgery date. Disease progression and vital status at last follow-up were evaluated. Analysis of metastatic PFS (defined by progression of systemic disease) benefit in relation to surgical timing was performed. Results: Multivariate analysis revealed patients having only one site of metastasis, negative margins, and Caucasian race had improved PFS. Further analysis revealed non-Caucasian patients more often underwent surgical intervention for palliation versus surgery for curative intent, possibly explaining their worse outcome. Patients who underwent surgery in the 3-8.9 month or later period had improved metastatic PFS. Conclusions: Surgical extirpation of the primary tumor in patients with synchronous stage IV disease is associated with improved metastatic PFS when performed more than 3 months after diagnosis. Resection should be planned with the intent of obtaining negative margins.

Original languageEnglish (US)
Pages (from-to)1696-1702
Number of pages7
JournalAnnals of Surgical Oncology
Volume15
Issue number6
DOIs
StatePublished - Jun 2008

Fingerprint

Breast Neoplasms
Disease-Free Survival
Disease Progression
Neoplasms
Radiotherapy
Multivariate Analysis
Demography
Neoplasm Metastasis
Survival

Keywords

  • Breast cancer
  • Breast surgery
  • Stage IV
  • Surgical timing

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Rao, R., Feng, L., Kuerer, H. M., Singletary, S. E., Bedrosian, I., Hunt, K. K., ... Babiera, G. V. (2008). Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Annals of Surgical Oncology, 15(6), 1696-1702. https://doi.org/10.1245/s10434-008-9830-4

Timing of surgical intervention for the intact primary in stage IV breast cancer patients. / Rao, Roshni; Feng, Lei; Kuerer, Henry M.; Singletary, S. Eva; Bedrosian, Isabelle; Hunt, Kelly K.; Ross, Merrick I.; Hortobagyi, Gabriel N.; Feig, Barry W.; Ames, Frederick C.; Babiera, Gildy V.

In: Annals of Surgical Oncology, Vol. 15, No. 6, 06.2008, p. 1696-1702.

Research output: Contribution to journalArticle

Rao, R, Feng, L, Kuerer, HM, Singletary, SE, Bedrosian, I, Hunt, KK, Ross, MI, Hortobagyi, GN, Feig, BW, Ames, FC & Babiera, GV 2008, 'Timing of surgical intervention for the intact primary in stage IV breast cancer patients', Annals of Surgical Oncology, vol. 15, no. 6, pp. 1696-1702. https://doi.org/10.1245/s10434-008-9830-4
Rao, Roshni ; Feng, Lei ; Kuerer, Henry M. ; Singletary, S. Eva ; Bedrosian, Isabelle ; Hunt, Kelly K. ; Ross, Merrick I. ; Hortobagyi, Gabriel N. ; Feig, Barry W. ; Ames, Frederick C. ; Babiera, Gildy V. / Timing of surgical intervention for the intact primary in stage IV breast cancer patients. In: Annals of Surgical Oncology. 2008 ; Vol. 15, No. 6. pp. 1696-1702.
@article{2d21ccf67a294d75bdbef14ae0cbd54d,
title = "Timing of surgical intervention for the intact primary in stage IV breast cancer patients",
abstract = "Background: Recent studies demonstrate improved progression-free survival (PFS) and improved overall survival (OS) with extirpation of the primary tumor in breast cancer patients who present with metastatic disease at initial diagnosis. The subset of patients who would most benefit from surgery remains unclear. This study evaluates the pathological attributes and optimum timing for surgery in patients who present with stage IV breast cancer and an intact primary. Methods: Retrospective, single-institution review of all breast cancer patients between 1997 and 2002 presenting with an intact tumor and synchronous metastatic disease. Information collected included: demographics, tumor characteristics, metastatic sites, type/timing of surgery, and radiation/systemic therapy received. Patients initiated treatment within 3 months of their diagnosis. Patients were divided into three groups based on time interval from diagnosis date to surgery date. Disease progression and vital status at last follow-up were evaluated. Analysis of metastatic PFS (defined by progression of systemic disease) benefit in relation to surgical timing was performed. Results: Multivariate analysis revealed patients having only one site of metastasis, negative margins, and Caucasian race had improved PFS. Further analysis revealed non-Caucasian patients more often underwent surgical intervention for palliation versus surgery for curative intent, possibly explaining their worse outcome. Patients who underwent surgery in the 3-8.9 month or later period had improved metastatic PFS. Conclusions: Surgical extirpation of the primary tumor in patients with synchronous stage IV disease is associated with improved metastatic PFS when performed more than 3 months after diagnosis. Resection should be planned with the intent of obtaining negative margins.",
keywords = "Breast cancer, Breast surgery, Stage IV, Surgical timing",
author = "Roshni Rao and Lei Feng and Kuerer, {Henry M.} and Singletary, {S. Eva} and Isabelle Bedrosian and Hunt, {Kelly K.} and Ross, {Merrick I.} and Hortobagyi, {Gabriel N.} and Feig, {Barry W.} and Ames, {Frederick C.} and Babiera, {Gildy V.}",
year = "2008",
month = "6",
doi = "10.1245/s10434-008-9830-4",
language = "English (US)",
volume = "15",
pages = "1696--1702",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Timing of surgical intervention for the intact primary in stage IV breast cancer patients

AU - Rao, Roshni

AU - Feng, Lei

AU - Kuerer, Henry M.

AU - Singletary, S. Eva

AU - Bedrosian, Isabelle

AU - Hunt, Kelly K.

AU - Ross, Merrick I.

AU - Hortobagyi, Gabriel N.

AU - Feig, Barry W.

AU - Ames, Frederick C.

AU - Babiera, Gildy V.

PY - 2008/6

Y1 - 2008/6

N2 - Background: Recent studies demonstrate improved progression-free survival (PFS) and improved overall survival (OS) with extirpation of the primary tumor in breast cancer patients who present with metastatic disease at initial diagnosis. The subset of patients who would most benefit from surgery remains unclear. This study evaluates the pathological attributes and optimum timing for surgery in patients who present with stage IV breast cancer and an intact primary. Methods: Retrospective, single-institution review of all breast cancer patients between 1997 and 2002 presenting with an intact tumor and synchronous metastatic disease. Information collected included: demographics, tumor characteristics, metastatic sites, type/timing of surgery, and radiation/systemic therapy received. Patients initiated treatment within 3 months of their diagnosis. Patients were divided into three groups based on time interval from diagnosis date to surgery date. Disease progression and vital status at last follow-up were evaluated. Analysis of metastatic PFS (defined by progression of systemic disease) benefit in relation to surgical timing was performed. Results: Multivariate analysis revealed patients having only one site of metastasis, negative margins, and Caucasian race had improved PFS. Further analysis revealed non-Caucasian patients more often underwent surgical intervention for palliation versus surgery for curative intent, possibly explaining their worse outcome. Patients who underwent surgery in the 3-8.9 month or later period had improved metastatic PFS. Conclusions: Surgical extirpation of the primary tumor in patients with synchronous stage IV disease is associated with improved metastatic PFS when performed more than 3 months after diagnosis. Resection should be planned with the intent of obtaining negative margins.

AB - Background: Recent studies demonstrate improved progression-free survival (PFS) and improved overall survival (OS) with extirpation of the primary tumor in breast cancer patients who present with metastatic disease at initial diagnosis. The subset of patients who would most benefit from surgery remains unclear. This study evaluates the pathological attributes and optimum timing for surgery in patients who present with stage IV breast cancer and an intact primary. Methods: Retrospective, single-institution review of all breast cancer patients between 1997 and 2002 presenting with an intact tumor and synchronous metastatic disease. Information collected included: demographics, tumor characteristics, metastatic sites, type/timing of surgery, and radiation/systemic therapy received. Patients initiated treatment within 3 months of their diagnosis. Patients were divided into three groups based on time interval from diagnosis date to surgery date. Disease progression and vital status at last follow-up were evaluated. Analysis of metastatic PFS (defined by progression of systemic disease) benefit in relation to surgical timing was performed. Results: Multivariate analysis revealed patients having only one site of metastasis, negative margins, and Caucasian race had improved PFS. Further analysis revealed non-Caucasian patients more often underwent surgical intervention for palliation versus surgery for curative intent, possibly explaining their worse outcome. Patients who underwent surgery in the 3-8.9 month or later period had improved metastatic PFS. Conclusions: Surgical extirpation of the primary tumor in patients with synchronous stage IV disease is associated with improved metastatic PFS when performed more than 3 months after diagnosis. Resection should be planned with the intent of obtaining negative margins.

KW - Breast cancer

KW - Breast surgery

KW - Stage IV

KW - Surgical timing

UR - http://www.scopus.com/inward/record.url?scp=43449124083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449124083&partnerID=8YFLogxK

U2 - 10.1245/s10434-008-9830-4

DO - 10.1245/s10434-008-9830-4

M3 - Article

C2 - 18357493

AN - SCOPUS:43449124083

VL - 15

SP - 1696

EP - 1702

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 6

ER -